Scientists have found a way to enhance t-cells to attack prostate cancer. The approach may involve targeting a specific aspect of cancer cells, but the details of the method are unclear. Additionally, there are reports of a related development, a low-cost blood test that can detect multiple cancers and other diseases from a single sample, although its connection to the t-cell treatment is not specified.